Minidiab Tablets 5mg contain the antihyperglycaemic medication, glipizide 5mg and are used to manage blood sugar levels in type 2 diabetics.
Type-2 diabetes is associated with increased risk of cardiovascular disease, blindness, kidney failure and stroke. The addition of Minidiab to a diabetes management plan of dietary improvements and regular exercise helps to improve the health outcomes for diabetics who have a shorter life expectancy.
Glipizide helps to control blood sugar levels by stimulating the release of insulin from the beta cells of the pancreas. Maintaining blood sugar control with Minidiab helps to reduce the risk of serious complications of diabetes such as blindness, nerve, and cardiovascular damage.